Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Mindy Mo"'
Publikováno v:
Respiratory Research, Vol 20, Iss 1, Pp 1-14 (2019)
Abstract Background Long-term use of inhaled corticosteroids (ICSs) has been associated with increased risk of bone and ocular comorbidities. We evaluated the effects of the triple fixed-dose combination budesonide/glycopyrrolate/formoterol fumarate
Externí odkaz:
https://doaj.org/article/8824f280ddfb4bae890046d22fc067f7
Autor:
Vladimir Hanes, Caroline Hamm, Alessandra Tucci, Mindy Mo, Cecily Forsyth, Dietger Niederwieser, David Chien, Patrick Cobb, Vincent Delwail, Roman Hájek
Publikováno v:
Targeted Oncology
Introduction ABP 798 is being developed as a biosimilar to rituximab reference product (RP), a CD20-directed cytolytic antibody that is approved in the US and EU for the treatment of non-Hodgkin lymphoma (NHL). Methods This randomized, double-blind,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd5dc97b60572be4ab27d33219d15589
http://europepmc.org/articles/PMC7568694
http://europepmc.org/articles/PMC7568694
Autor:
Emily Martin, Godwin Yung, Juliane Manitz, Mindy Mo, Rui Sammi Tang, Vincent Haddad, Kaspar Rufibach, Fei Jie, Hannes Buchner, Jyotirmoy Dey, Marie-Laure Casadebaig, Jiangxiu Zhou, Natalia Kan-Dobrosky, Yue Shentu, Viktoriya Stalbovskaya, Evgeny Degtyarev
Publikováno v:
Pharmaceutical statisticsREFERENCES. 21(1)
An addendum of the ICH E9 guideline on Statistical Principles for Clinical Trials was released in November 2019 introducing the estimand framework. This new framework aims to align trial objectives and statistical analyses by requiring a precise defi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99cd9e907f9bb0a80ab88cb0dcf3d6d0
https://pubmed.ncbi.nlm.nih.gov/34605168
https://pubmed.ncbi.nlm.nih.gov/34605168
Autor:
Shaila Ballal, Paul Dorinsky, Paolo DePetrillo, Kiernan DeAngelis, Roopa Trivedi, Michael Gillen, Mindy Mo
Publikováno v:
Airway pharmacology and treatment.
Objective: To assess the effect of a spacer device on lung exposure, total systemic exposure and safety of BGF MDI, a triple fixed-dose ICS/LAMA/LABA combination formulated using co-suspension delivery technology. Methods: In this Phase I, randomized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3490db2c6bca7f6e97f46e7f31d1145a
https://doi.org/10.1183/13993003.congress-2019.pa3376
https://doi.org/10.1183/13993003.congress-2019.pa3376
Publikováno v:
Respiratory Research, Vol 20, Iss 1, Pp 1-14 (2019)
Respiratory Research
Respiratory Research
Background Long-term use of inhaled corticosteroids (ICSs) has been associated with increased risk of bone and ocular comorbidities. We evaluated the effects of the triple fixed-dose combination budesonide/glycopyrrolate/formoterol fumarate metered d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c019ce460a341313d9d6dbb632a0df2
https://doi.org/10.1186/s12931-019-1126-7
https://doi.org/10.1186/s12931-019-1126-7
Publikováno v:
B45. COPD: TREATMENT.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67084b594a464c119ecd1bc678419c67
https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3319
https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3319
Publikováno v:
B45. COPD: TREATMENT.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ef06f10665affe5e1791fc75c196884
https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3321
https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3321
Autor:
Dietger Niederwieser, Caroline Hamm, Patrick Cobb, Mindy Mo, Cecily Forsyth, Alessandra Tucci, Vladimir Hanes, Vincent Delwail, Roman Hajek, David Chien
Publikováno v:
Targeted Oncology. 15:807-807
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6af0ebc2fca12d309ed2b7cdf14e9ed8
https://doi.org/10.1007/s11523-020-00772-4
https://doi.org/10.1007/s11523-020-00772-4
Autor:
Roman Hájek, Vincent Delwail, David Chien, Dietger Niederwieser, Cecily Forsyth, Vladimir Hanes, Patrick Wayne Cobb, Alessandra Tucci, Caroline Hamm, Mindy Mo
Publikováno v:
Journal of Clinical Oncology. 38:8044-8044
8044 Background: ABP 798* is being developed as a biosimilar to rituximab, a CD20-directed cytolytic antibody. A randomized, double-blind, active-controlled study compared the efficacy, safety, and immunogenicity of ABP 798 with rituximab reference p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15d6419a0073c65679274f9e3c645f25
https://doi.org/10.1200/jco.2020.38.15_suppl.8044
https://doi.org/10.1200/jco.2020.38.15_suppl.8044